seed
Stage
2018
Founded
1
Investors
About
Nostics develops rapid, point-of-care diagnostic solutions using Raman spectroscopy, nanotechnology and AI to identify bacterial and other pathogens directly from patient samples within minutes, enabling targeted antibiotic prescribing and improving patient outcomes.
Explore Nostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.